| Literature DB >> 35930578 |
Yooyeon Park1, Hae Ri Yum2, Sun Young Shin3, Shin Hae Park3.
Abstract
PURPOSE: To analyze ocular biometric changes following unilateral cataract surgery in children.Entities:
Mesh:
Year: 2022 PMID: 35930578 PMCID: PMC9355217 DOI: 10.1371/journal.pone.0272369
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Clinical characteristics of 57 children who underwent unilateral cataract surgery.
| Clinical characteristics | No (%) |
|---|---|
| Male: Female | 27: 30 |
| Birth Hx, full-term: preterm | 56: 1 |
| Family Hx of congenital cataracts | 2 (3.5%) |
| Bilaterality of cataract | |
| Bilateral | 12 (21.1%) |
| Unilateral | 45 (78.9%) |
| Cause of cataract (69 eyes) | |
| Congenital/developmental cataract | 60 (87.0%) |
| Traumatic cataract | 4 (5.8%) |
| Complicated cataract | 5 (7.2%) |
| Type of cataract (69 eyes) | |
| Anterior subcapsular | 4 (5.8%) |
| Nuclear or lamellar | 20 (29.0%) |
| Posterior subcapsular or posterior lenticonus | 45 (65.2%) |
| Surgical eye, right: left | 24: 33 |
| Surgical procedure (57 eyes) | |
| Posterior CCC with anterior vitrectomy | 24 (42.1%) |
| Primary/secondary IOL implantation | 55 (96.5%) / 2 (3.5%) |
| In the bag / sulcus insertion | 50 (87.7%) / 7 (12.3%) |
| Complications after surgery | |
| PCO | 24 (42.1%) |
| Nd-Yag laser posterior capsulotomy | 20 (35.1%) |
| Surgical pars plana posterior capsulotomy | 4 (7.0%) |
| IOL opacification | 2 (3.5%) |
| Cortex remnant | 2 (3.5%) |
| High IOP | 0 (0.0%) |
Hx, history; CCC, continuous curvilinear capsulorhexis; IOL, intraocular lens; PCO, posterior capsular opacity; IOP, intraocular pressure
Ocular biometric findings of pseudophakic eyes at the time of IOL implantation and one-month postoperatively.
| Group | All | I (Infant/toddler) age <3 | II (Preschool) 3≤ age <6 | III (Early-school) 6≤ age <9 | IV (Late-school) age ≥9 | P-value |
|---|---|---|---|---|---|---|
| Number of eyes | 57 | 6 | 14 | 18 | 19 | |
| Age at IOL implantation (year) | 7.55 ± 3.57 | 1.77 ± 0.78 | 4.25 ± 0.72 | 7.93 ± 0.75 | 11.46 ± 1.62 | <0.001a |
| AL (mm) | 22.78 ± 1.47 | 20.43 ± 1.69 | 22.32 ± 1.38 | 23.16 ± 1.08 | 23.58 ± 0.87 | 0.001a |
| Mean K (D) | ||||||
| Preoperative | 43.29 ± 1.58 | 43.79 ± 2.63 | 42.95 ± 1.85 | 43.37 ± 1.20 | 43.36 ± 1.65 | 0.734 |
| Postoperative 1-month | 43.76 ± 1.60 | 45.50 | 43.75 ± 1.40 | 43.58 ± 1.15 | 43.79 ± 2.36 | 0.601 |
| SE (D) | ||||||
| Preoperative | -0.46 ± 4.16 | -4.31 ± 7.51 | +0.45 ± 3.36 | +0.47 ± 4.33 | -1.16 ± 4.18 | 0.278 |
| Postoperative 1-month | +0.50 ± 1.97 | +1.92 ± 4.71 | +1.25 ± 1.52 | +0.49 ± 0.99 | -0.50 ± 1.08 | 0.011a |
| Anticipated target (SRK II) | +0.67 ± 1.45 | +3.00 ± 2.28 | +1.24 ± 1.18 | +0.74 ± 0.64 | -0.52 ± 0.90 | <0.001a |
| P-valueb | 0.882 | 0.715 | 0.861 | 0.394 | 0.691 | |
| BCVA (logMAR) | ||||||
| Preoperative | 0.87 ± 0.63 | N/A | 0.94 ± 0.67 | 0.73 ± 0.29 | 0.95 ± 0.82 | 0.679 |
| Postoperative 1-month | 0.37 ± 0.30 | 0.60 | 0.57 ± 0.31 | 0.35 ± 0.21 | 0.24 ± 0.30 | 0.003a |
| P-value | <0.001b | N/A | 0.036b | <0.001b | <0.001b |
AL, axial length; K, keratometry; D, diopter; SE, spherical equivalent; BCVA, best-corrected visual acuity; N/A, not applicable
The data are expressed as means ± standard deviations.
aComparison was performed using the Kruskal Wallis H test. Significant values at P < 0.05.
bPostoperative 1-month SE and anticipated target were compared, and preoperative BCVA was compared with postoperative BCVA. Comparison was performed using the Wilcoxon signed-rank test. Significant values at P < 0.05.
Comparison of myopic shift and axial eye growth of pseudophakic eyes and fellow phakic eyes during the total follow-up period after unilateral pediatric cataract surgery.
| Spherical equivalent change | |||||||
| Group (age at IOL implantation) | Follow-up period (year) | Overall myopic shift (D) | Rate of myopic shift (D/year) | ||||
| Pseudophakic eye | Phakic eye | P-value | Pseudophakic eye | Phakic eye | P-value | ||
| All | 7.81 ± 4.39 | -3.25 ± 3.21 | -1.78 ± 2.10 | 0.01a | -0.45 ± 0.44 | -0.22 ± 0.29 | 0.004a |
| I (age <3) | 6.65 ± 3.36 | -6.46 ± 4.12 | -0.52 ± 2.09 | 0.009a | -1.14 ± 0.66 | -0.02 ± 0.45 | 0.009a |
| II (3≤ age <6) | 6.94 ± 3.05 | -5.07 ± 3.91 | -2.46 ± 2.82 | 0.056 | -0.63 ± 0.37 | -0.31 ± 0.29 | 0.014a |
| III (6≤ age <9) | 8.13 ± 5.28 | -2.43 ± 2.00 | -1.93 ± 1.98 | 0.496 | -0.30 ± 0.21 | -0.23 ± 0.30 | 0.339 |
| IV (age ≥9) | 8.52 ± 4.70 | -1.62 ± 1.63 | -1.55 ± 1.43 | 0.908 | -0.23 ± 0.27 | -0.21 ± 0.20 | 0.977 |
| P-value | 0.001b | 0.429 | <0.001b | 0.502 | |||
| Axial length change | |||||||
| Group (age at IOL implantation) | Follow-up period (year) | Overall axial eye growth (mm) | Rate of axial eye growth (mm/year) | ||||
| Pseudophakic eye | Phakic eye | P-value | Pseudophakic eye | Phakic eye | P-value | ||
| All | 6.33 ± 2.98 | 1.49 ± 1.14 | 1.42 ± 0.91 | 0.94 | 0.23 ± 0.16 | 0.26 ± 0.15 | 0.504 |
| I (age <3) | 7.35 ± 3.02 | 2.83 ± 1.16 | 2.15 ± 1.69 | 0.486 | 0.32 ± 0.07 | 0.25 ± 0.17 | 0.886 |
| II (3≤ age <6) | 6.26 ± 2.90 | 2.11 ± 1.34 | 1.66 ±0.93 | 0.512 | 0.33 ± 0.15 | 0.29 ± 0.10 | 0.468 |
| III (6≤ age <9) | 6.02 ± 3.19 | 0.98 ± 0.51 | 1.12 ± 0.53 | 0.606 | 0.17 ± 0.12 | 0.25 ± 0.19 | 0.243 |
| IV (age ≥9) | 6.32 ± 2.92 | 0.88 ± 0.65 | 0.99 ± 0.29 | 0.743 | 0.18 ± 0.18 | 0.23 ± 0.18 | 0.583 |
| P-value | 0.006b | 0.494 | 0.015b | 0.787 | |||
IOL, intraocular lens; D, diopter
The data are expressed as means ± standard deviations.
aComparison was performed using the Mann-Whitney U test. Significant values at P < 0.05.
bComparison was performed using the Kruskal Wallis H test. Significant values at P < 0.05.
Fig 1Ten years of spherical equivalent values on the pseudophakic and fellow phakic eyes in the four groups divided by age.
(A) Group I had the steepest yearly change in spherical equivalent in the pseudophakic eyes among the four age groups at -1.11 D (R2 = 0.954), followed by group II at -0.91 D (R2 = 0.979), group III at -0.42 D (R2 = 0.975), and group IV at -0.20 D (R2 = 0.674) (P < 0.001). (B) No significant difference was shown in yearly SE changes in the phakic eyes among the age groups (-0.39 D in group I; -0.52 D in group II; -0.29 D in group III; and -0.14 D in group IV, P = 0.502).
Keratometry values of pseudophakic and fellow phakic eyes at postoperative one-month and at final follow-up after unilateral pediatric cataract surgery.
| Group (age at IOL implantation) | Steep K (D) at postop. 1-month | Flat K (D) at postop. 1-month | ||||
| Pseudophakic eye | Phakic eye | P-value | Pseudophakic eye | Phakic eye | P-value | |
| All | 44.78 ± 1.77 | 43.87 ± 1.39 | 0.058 | 42.73 ± 1.63 | 42.57 ± 1.60 | 0.671 |
| I (age <3) | 47.50 | 45.25 | N/A | 43.50 | 43.00 | N/A |
| II (3≤ age <6) | 44.44 ± 1.66 | 43.90 ± 1.83 | 0.556 | 43.06 ± 1.14 | 42.80 ± 1.81 | 0.73 |
| III (6≤ age <9) | 44.59 ± 1.23 | 44.08 ± 1.16 | 0.173 | 42.57 ± 1.37 | 42.63 ± 1.45 | 0.809 |
| IV (age ≥9) | 44.89 ± 2.48 | 43.15 ± 1.43 | 0.202 | 42.68 ± 2.39 | 42.15 ± 2.09 | 0.755 |
| P-value | 0.517 | 0.4 | 0.769 | 0.988 | ||
| Group (age at IOL implantation) | Steep K (D) at final follow-up | Flat K (D) at final follow-up | ||||
| Pseudophakic eye | Phakic eye | P-value | Pseudophakic eye | Phakic eye | P-value | |
| All | 44.37 ± 2.09 | 43.68 ± 1.94 | 0.096 | 41.93 ± 1.94 | 42.18 ± 1.86 | 0.772 |
| I (age <3) | 44.93 ± 1.84 | 43.75 ± 1.41 | 0.533 | 42.74 ± 1.56 | 41.88 ± 1.59 | 0.533 |
| II (3≤ age <6) | 44.74 ± 2.11 | 44.48 ± 3.06 | 0.927 | 42.60 ± 2.25 | 42.42 ± 2.53 | 1.0 |
| III (6≤ age <9) | 44.33 ± 1.49 | 43.66 ± 1.63 | 0.21 | 41.89 ± 1.50 | 42.38 ± 1.62 | 0.547 |
| IV (age ≥9) | 44.02 ± 2.74 | 43.33 ± 1.95 | 0.471 | 41.37 ± 2.26 | 41.97 ± 2.09 | 0.695 |
| P-value | 0.733 | 0.659 | 0.559 | 0.707 | ||
IOL, intraocular lens; K, keratometry; D, diopter; postop., postoperative day; K-diff, difference in steep-flat K; N/A, not applicable
The data are expressed as means ± standard deviations.
aComparison was performed using the Mann-Whitney U test. Significant values at P < 0.05.
bComparison was performed using the Kruskal Wallis H test. Significant values at P < 0.05.
Previous studies on refractive changes after unilateral pediatric cataract surgery.
| References | Ethnic population | No. of eyes | Age at IOL implantation (years), mean (range) | Mean rate of refractive change (D/year) | Follow-up years, mean (range) | |
|---|---|---|---|---|---|---|
| Pseudophakic eye | Fellow eye | |||||
| Enyedi et al. | United States | 83 | 6.3 (0.75–17) | -0.65 | -0.12 | 2.2 (0.5–6.6) |
| (-1.2 in age≤2) | ||||||
| Yam et al. | Hong Kong Chinese | 32 | 7.3 (1.5–17) | -0.84 | -0.24 | 4.4 (2–9) |
| (-0.91 in age≤2) | ||||||
| Sminia et al. | Netherlands | 20 | 4.1 (2.2–8) | -0.21 | -0.23 | 4.8 (1.8–11.1) |
| 25 | 0.4 (0.06–1.4) | -1.40 | -0.40 | 4.3 (1.0–11.9) | ||
| Weakley et al. | United States | 108 | 0.2 (0.08–0.6) | -2.12 | - | 4.9 (0.9–5.4) |
| Yang et al. [ | Taiwanese | 62 | 5.6 (1–9.8) | -0.46 | -0.23 | 3.6 (1–9.75) |
| Present study | Korean | 114 | 7.6 (0.5–15.6) | -0.45 | -0.22 | 7.8 (2.2–21.6) |
| (-1.14 in age<3) | ||||||
IOL, intraocular lens; D, diopter
*The Infant Aphakia Treatment Study
a The patients were divided into two groups based on an age of 18 months.
b Studies with different ethnicities that have demonstrated a significantly higher rate of refractive change (D/year) in pseudophakic eyes than in fellow phakic eyes.